MetLife Investment Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $294K | Hold |
26,668
| – | – | ﹤0.01% | 1968 |
|
|
2025
Q1 | $238K | Hold |
26,668
| – | – | ﹤0.01% | 2108 |
|
|
2024
Q4 | $251K | Hold |
26,668
| – | – | ﹤0.01% | 2185 |
|
|
2024
Q3 | $215K | Sell |
26,668
-897
| -3% | -$7.23K | ﹤0.01% | 2250 |
|
|
2024
Q2 | $234K | Buy |
27,565
+5,549
| +25% | +$47.1K | ﹤0.01% | 2146 |
|
|
2024
Q1 | $197K | Sell |
22,016
-7,562
| -26% | -$67.8K | ﹤0.01% | 2212 |
|
|
2023
Q4 | $332K | Sell |
29,578
-4,364
| -13% | -$49.1K | ﹤0.01% | 1932 |
|
|
2023
Q3 | $293K | Hold |
33,942
| – | – | ﹤0.01% | 1975 |
|
|
2023
Q2 | $351K | Hold |
33,942
| – | – | ﹤0.01% | 1924 |
|
|
2023
Q1 | $368K | Hold |
33,942
| – | – | ﹤0.01% | 1839 |
|
|
2022
Q4 | $381K | Hold |
33,942
| – | – | ﹤0.01% | 1820 |
|
|
2022
Q3 | $344K | Hold |
33,942
| – | – | ﹤0.01% | 1901 |
|
|
2022
Q2 | $308K | Hold |
33,942
| – | – | ﹤0.01% | 2005 |
|
|
2022
Q1 | $324K | Buy |
33,942
+12,090
| +55% | +$116K | ﹤0.01% | 2053 |
|
|
2021
Q4 | $241K | Buy |
21,852
+15,298
| +233% | +$169K | ﹤0.01% | 1941 |
|
|
2021
Q3 | $48.5K | Sell |
6,554
-11,970
| -65% | -$88.6K | ﹤0.01% | 2536 |
|
|
2021
Q2 | $269K | Hold |
18,524
| – | – | ﹤0.01% | 1961 |
|
|
2021
Q1 | $378K | Sell |
18,524
-2,730
| -13% | -$55.7K | ﹤0.01% | 1681 |
|
|
2020
Q4 | $378K | Hold |
21,254
| – | – | ﹤0.01% | 1615 |
|
|
2020
Q3 | $314K | Hold |
21,254
| – | – | ﹤0.01% | 1606 |
|
|
2020
Q2 | $446K | Hold |
21,254
| – | – | 0.01% | 1446 |
|
|
2020
Q1 | $491K | Buy |
21,254
+1,564
| +8% | +$36.1K | 0.01% | 1226 |
|
|
2019
Q4 | $510K | Hold |
19,690
| – | – | 0.01% | 1452 |
|
|
2019
Q3 | $384K | Hold |
19,690
| – | – | ﹤0.01% | 1564 |
|
|
2019
Q2 | $322K | Hold |
19,690
| – | – | ﹤0.01% | 1753 |
|
|
2019
Q1 | $446K | Hold |
19,690
| – | – | ﹤0.01% | 1522 |
|
|
2018
Q4 | $504K | Hold |
19,690
| – | – | 0.01% | 1366 |
|
|
2018
Q3 | $643K | Buy |
+19,690
| New | +$643K | 0.01% | 1372 |
|